Filana Therapeutics, Inc. Common Stock (NASDAQ: FLNA) last traded at $0.766, down 6.24% on the session. The quote above updates while this page is open; the figures below are drawn from Filana Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Filana Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker FLNA. Its market capitalisation is $36.99 million.
Valuation measures for Filana Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $36.99M |
|---|---|
| Enterprise value | -$9.35M |
| Price / book | 0.54 |
| Beta | 1.87 |
Trailing-twelve-month figures tagged in Filana Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$77.90M |
| EPS (TTM) | -$1.61 |
|---|
| Return on equity | -114.32% |
|---|
| Cash | $86.57M |
|---|
Range and volume for FLNA over the past 52 weeks.
| 52-week high | $4.98 |
|---|---|
| 52-week low | $0.670 |
| Volume | 259.5K |
| Average volume | 2.00M |
| Previous close | $0.817 |
Invest a chosen dollar amount in Filana Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell FLNA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.